Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV

J Microbiol Immunol Infect. 2020 Jun;53(3):365-367. doi: 10.1016/j.jmii.2020.02.001. Epub 2020 Feb 4.

Authors

Ping-Ing Lee¹, Po-Ren Hsueh²

Affiliations

¹ Department of Pediatrics, National Taiwan University Children's Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: pinging@ntu.edu.tw.
² Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.

No abstract available

MeSH terms

Animals
Antiviral Agents / therapeutic use
Betacoronavirus / pathogenicity
COVID-19
Communicable Diseases, Emerging / epidemiology
Communicable Diseases, Emerging / therapy*
Communicable Diseases, Emerging / transmission
Communicable Diseases, Emerging / virology
Coronavirus / pathogenicity
Coronavirus Infections / epidemiology
Coronavirus Infections / therapy*
Coronavirus Infections / virology
Host Specificity
Humans
Pandemics / veterinary
Pneumonia, Viral / epidemiology
Pneumonia, Viral / therapy*
Pneumonia, Viral / veterinary
Pneumonia, Viral / virology
SARS-CoV-2
Severe Acute Respiratory Syndrome / epidemiology
Severe Acute Respiratory Syndrome / therapy*
Severe Acute Respiratory Syndrome / veterinary
Severe Acute Respiratory Syndrome / virology
Zoonoses / therapy*
Zoonoses / transmission
Zoonoses / virology

Substances

Antiviral Agents